Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bauch

Showing results (601-610 of 610) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 610 results.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
European Journal of Medicinal Chemistry|December 29, 2023
Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)Cédric Couturier, Quentin Ronzon, Giulia Lattanzi, et al.
Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Nature|January 24, 2002
Functional organization of the yeast proteome by systematic analysis of protein complexesAnne-Claude Gavin, Markus Bösche, Roland Krause, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor modelsCherrie K Donawho, Yan Luo, Yanping Luo, et al.
Nature Ecology & Evolution|February 11, 2022
Palaeoecological data indicates land-use changes across Europe linked to spatial heterogeneity in mortality during the Black Death pandemicA Izdebski, P Guzowski, R Poniat, et al.
Frontiers in Immunology|February 28, 2024
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approachesAnna Niarakis, Marek Ostaszewski, Alexander Mazein, et al.
Molecular Systems Biology|October 19, 2021
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanismsMarek Ostaszewski, Anna Niarakis, Alexander Mazein, et al.
Pageof 61

Showing results (601-610 of 610) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 610 results.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
European Journal of Medicinal Chemistry|December 29, 2023
Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)Cédric Couturier, Quentin Ronzon, Giulia Lattanzi, et al.
Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Nature|January 24, 2002
Functional organization of the yeast proteome by systematic analysis of protein complexesAnne-Claude Gavin, Markus Bösche, Roland Krause, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor modelsCherrie K Donawho, Yan Luo, Yanping Luo, et al.
Nature Ecology & Evolution|February 11, 2022
Palaeoecological data indicates land-use changes across Europe linked to spatial heterogeneity in mortality during the Black Death pandemicA Izdebski, P Guzowski, R Poniat, et al.
Frontiers in Immunology|February 28, 2024
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approachesAnna Niarakis, Marek Ostaszewski, Alexander Mazein, et al.
Molecular Systems Biology|October 19, 2021
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanismsMarek Ostaszewski, Anna Niarakis, Alexander Mazein, et al.
Pageof 61